{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:20:56Z","timestamp":1783786856166,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmg.2021.104260","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T22:16:02Z","timestamp":1623276962000},"page":"104260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-6011","authenticated-orcid":false,"given":"Ivana","family":"Radulovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Kuechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Sch\u00fcndeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"von Neuhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Hanenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmg.2021.104260_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104260_bib2","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2010-12-324541","article-title":"A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay","volume":"118","author":"Biswas","year":"2011","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.ejmg.2021.104260_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cancergen.2015.11.005","article-title":"Biallelic FANCD1\/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications","volume":"209","author":"Dodgshun","year":"2016","journal-title":"Cancer genetics"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104260_bib4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"issue":"5581","key":"10.1016\/j.ejmg.2021.104260_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104260_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1651-2227.2010.02116.x","article-title":"Hepatoblastoma in a 4-year-old girl with Fanconi anaemia","volume":"100","author":"Kopic","year":"2011","journal-title":"Acta Paediatr."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104260_bib7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the international Fanconi anemia registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"7354","key":"10.1016\/j.ejmg.2021.104260_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejmg.2021.104260_bib9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/15384101.2017.1320627","article-title":"Persistent response of Fanconi anemia haematopoietic stem and progenitor cells to oxidative stress","volume":"16","author":"Li","year":"2017","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.ejmg.2021.104260_bib10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1101\/gad.11.10.1226","article-title":"Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1\/Brca2, Brca1\/p53, and Brca2\/p53 nullizygous embryos","volume":"11","author":"Ludwig","year":"1997","journal-title":"Genes & development"},{"issue":"3","key":"10.1016\/j.ejmg.2021.104260_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pbc.25303","article-title":"Fanconi anemia and solid malignancies in childhood: a national retrospective study","volume":"62","author":"Malric","year":"2015","journal-title":"Pediatr. Blood Canc."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104260_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/jmedgenet-2013-101642","article-title":"Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling","volume":"51","author":"Meyer","year":"2014","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104260_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.12634","article-title":"Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia","volume":"164","author":"Mitchell","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104260_bib14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/pbc.23168","article-title":"The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1\/BRCA2 mutations","volume":"58","author":"Myers","year":"2012","journal-title":"Pediatr. Blood Canc."},{"key":"10.1016\/j.ejmg.2021.104260_bib15","first-page":"457","article-title":"The Fanconi anemia pathway in cancer","volume":"3","author":"Niraj","year":"2019","journal-title":"Annu. Rev. Cell Biol."},{"issue":"20","key":"10.1016\/j.ejmg.2021.104260_bib16","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/jnci\/djg072","article-title":"Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia","volume":"95","author":"Offit","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"9999","key":"10.1016\/j.ejmg.2021.104260_bib17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(14)62395-3","article-title":"Omission of doxorubicin from the treatment of stage II\u2013III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial","volume":"386","author":"Pritchard-Jones","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejmg.2021.104260_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jmg.2004.022673","article-title":"Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour","volume":"42","author":"Reid","year":"2005","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104260_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104260_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat. Rev. Canc."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104260_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2016.04.006","article-title":"Fanconi anemia proteins function in mitophagy and immunity","volume":"165","author":"Sumpter","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejmg.2021.104260_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.ejmg.2021.104260_bib23","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/hmg\/ddw066","article-title":"BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation","volume":"25","author":"Thirthagiri","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.ejmg.2021.104260_bib24","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-10-3243","article-title":"Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor","volume":"101","author":"T\u00f6nnies","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ejmg.2021.104260_bib25","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","article-title":"Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104260_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.stem.2016.03.002","article-title":"TGF-\u03b2 inhibition rescues hematopoietic stem cell defects and bone marrow failure in Fanconi anemia","volume":"18","author":"Zhang","year":"2016","journal-title":"Cell Stem Cell"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221001269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221001269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:50:07Z","timestamp":1761709807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1769721221001269"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104260","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104260"}}